Davis Polk advised Crestview, and Sidley Austin advised Gersch. Leading talent agency, The Gersh Agency has partnered with New York-based private equity firm Crestview Partners as a strategic...
Crestview’s Strategic Investment in The Gersh Agency
Alight’s $476 Million Secondary Offering
Davis Polk advised the representatives of the several underwriters on the offering. Alight, Inc. announced an SEC-registered offering of 52,900,000 shares of Class A common stock...
Trane Technologies’ $700 Million Senior Notes Offering
King & Spalding advised Trane Technologies, Arthur Cox advised TTFL, Trane plc and Irish Holdings, Loyens & Loeff advised Lux International, and Davis Polk advised the...
V.F. Corporation’s €500 Million Senior Notes and €500 Million Green Bond Offering
Davis Polk advised V.F. Corporation on the offering, and Simpson Thacher advised the underwriters involved. V.F. Corporation announced the offering of €1 billion aggregate principal amount...
Bumble’s $313.5 Million Secondary Offering
Simpson Thacher advised Bumble Inc., and Davis Polk advised the representatives of the several underwriters. Bumble Inc. announced the $313.5 million SEC-registered offering by certain selling...
Sun Country Airlines’ Common Stock Offering
Paul, Weiss, Rifkind, Wharton & Garrison represented Sun Country Airlines, Inc. and Apollo Global Management, Inc., while Davis Polk & Wardwell acted as counsel for the...
Williams’ Acquisition of MountainWest Pipelines Holding Company
Davis Polk advised Williams on the transaction. Williams announced its acquisition of MountainWest Pipelines Holding Company from Southwest Gas Holdings Inc. for an enterprise value of...
Kinsale Capital Group’s $48 Million Follow-on Offering
Skadden advised Kinsale Capital Group, while Davis Polk advised J.P. Morgan Securities, the underwriter, in the offering. Kinsale Capital Group, Inc. executed its $48 million follow-on offering...
Recursion Pharmaceuticals’ $150 Million Private Placement
Davis Polk advised the placement agents in the transaction. Recursion Pharmaceuticals executed its $150 million private placement of common stock. Morgan Stanley & Co. LLC acted as the...
IDEAYA Biosciences’ $80 Million Common Stock Offering
Latham & Watkins represented IDEAYA, while Davis Polk advised the representatives of the several underwriters in the offering. IDEAYA Biosciences, Inc. (Nasdaq: IDYA) announced the pricing of an...
Roper Technologies’ Acquisition of Frontline Education
Cooley advised Frontline Education, while Davis Polk and Jones Day advised Roper Technologies on the deal. Kirkland & Ellis advised Thoma Bravo. Frontline Education, a leading...
Terns Pharmaceuticals’ $65 Million Common Stock Offering
Latham & Watkins represented Terns Pharmaceuticals in the offering, while Davis Polk & Wardwell represented the underwriters. Terns Pharmaceuticals, Inc. (Nasdaq: TERN) has agreed to sell, by...